Author

N. E. Navin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Ahmed· 1 shared A. B. Heimberger· 1 shared A. C. Adey· 1 shared A. Goldman· 1 shared A. L. Creason· 1 shared A. Maheshwari· 1 shared B. E. Johnson· 1 shared C. K. Matsuoka· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Ahmed

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers

A. L. Creason, J. Egger, C. Watson, S. Sivagnanam, K. Chin, K. MacPherson, J.-R. Lin, Y.-A. Chen, B. E. Johnson, H. S. Feiler, D. Galipeau, N. E. Navin, E. Demir, Y. H. Chang, C. L. Corless, , J. Goecks

This study creates a multimodal tumor atlas to analyze how metastatic HR+ breast cancers adapt to CDK4/6 inhibitors, revealing mechanisms like mTORC1 activation and immune microenvironment changes.

bioRxiv · Sep 27, 2023 · PreprintCancer Biology

Immune Contexture of Isocitrate Dehydrogenase stratified Human Gliomas

P. Gupta, M. Dang, S. Oberai, M. M. Peshoff, N. Milam, A. Ahmed, K. Bojja, T. M. Tran, K. Cox, H. Shehwana, C. K. Matsuoka, J. Li, J. Gumin, A. Goldman, S. A. Seth, , K. P. Bhat

The paper provides a comprehensive analysis of immune contexture in IDH stratified human gliomas using single-cell RNA sequencing and spectral cytometry, identifying TREM2 as a novel immunotherapy target.

bioRxiv · Nov 8, 2022Immunology